Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 1116 Great Plain Ave,
- Industry
- Biotechnology
- Website
- http://www.remedium-bio.com
- HQ
- Needham, Massachusetts
Remedium Bio Questions
Remedium Bio's website is http://www.remedium-bio.com
Remedium Bio's LinkedIn profile is https://www.linkedin.com/company/remedium-bio
Remedium Bio has
14 employees.
View email and phone details for 14
employees at Remedium Bio.
Remedium Bio's industry is
Biotechnology
Remedium Bio's top competitors are
Anika,
Radiant Biotherapeutics,
Superluminal Medicines Inc.,
Solu Therapeutics,
Strand Therapeutics,
Orna Therapeutics,
Candid Therapeutics,
Liberate Bio,
Alnylam Pharmaceuticals,
Ensoma.
Remedium Bio's categories are Biotechnology
Remedium Bio's founding year is 2020
